McKesson is trading at $842.00, down 4.02%, after investors digested its August 5 earnings release, with concern focused on Medical-Surgical weakness.
- Shares had gained 5.64% to $877.23 after the quarter beat expectations and FY2027 adjusted EPS guidance increased to $44.20–$45.00.
- Medical-Surgical Solutions adjusted operating profit fell 20%, while free cash flow was negative $372 million.
- Healthcare remains supportive; the decline appears primarily company-specific profit-taking and segment-quality concerns.